Medizinische Medien Informations GmbH

What Medizinische Medien Informations GmbH does

Vidal MMI Germany GmbH (operating as Medizinische Medien Informations GmbH / MMI) is a German healthcare information company founded in 1970 and headquartered in Langen, Germany. The company provides certified pharmaceutical drug databases, medication therapy safety (AMTS) software, and electronic prescription tools used by physicians, clinics, nursing homes, pharmacies, healthcare authorities, statutory health insurance funds, and healthcare IT companies. Its core product line, MMI Pharmindex, is offered in three tiers (Plus desktop software, Pro web service API, and Rohdaten raw data) and is integrated into practice management systems (PVS) and clinic software via standardized APIs. Supporting products include the MMI-AMTS-Service (platform-independent medication safety for software houses), data4doc (KBV-certified electronic prescription software, free for dental practices), and the medic Cloud-Service for real-time data delivery into third-party applications and mobile apps.

The company monetizes through recurring subscriptions for database licenses and e-prescription software, one-time media sales, advertising on its Gelbe Liste Online platform, and licensing/royalty arrangements for raw data and web services sold to software houses. It operates multiple go-to-market motions including direct enterprise field sales targeting PVS providers and statutory health insurance funds, inside sales with digital marketing and product demos, and self-serve PLG through website registration, cloud services, and mobile app downloads. Sub-brands include Gelbe Liste Pharmindex (cross-media drug information for healthcare professionals), Gelbe Liste Campus (CME continuing education), Rehakliniken (rehabilitation facility directory), and Meine Gesundheit (patient portal). The company has been a subsidiary of M3 Inc. (Tokyo Stock Exchange: 2413.T) since 2016 through the VIDAL Group and operates exclusively in the German/DACH market.

Name

Medizinische Medien Informations GmbH

Legal name

Vidal MMI Germany GmbH

Website

https://mmi.de

Company type

Private

Founded year

1970

Operating status

Operating

Headcount range

11–50 employees

Short description

Vidal MMI Germany (Medizinische Medien Informations GmbH) provides certified pharmaceutical drug databases, medication safety software, and KBV-certified electronic prescribing tools for physicians, clinics, nursing homes, pharmacies, health authorities, and healthcare IT companies in Germany.

Ownership category

akta.pro rank

Product category

Healthcare Information / Pharmaceutical Data Software

SIC

Services-Health Services (8000)

akta.pro industry

PRIMARYHLACAKAH

Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools

Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT

SECONDARYHLACAKAL

Medication Analytics, Outcomes & Cost Optimization

Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT

SECONDARYHLALAIAG

Medication Adherence & Therapy Management Platforms (refills, reminders, MTM)

Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms

Keywords

• Pharmaceutical drug databases
• Medication therapy safety software
• Electronic prescribing software
• Healthcare data services
• Medical reference platforms

Headquarters

HQ city

Langen

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Pharmaceutical Database Licenses: Licensing of certified drug databases (MMI Pharmindex Plus, Pro) to physicians, clinics, nursing homes, authorities and healthcare companies. Revenue from software subscriptions and data service agreements.
2. Prescription Software (data4doc): KBV-certified electronic prescription software sold to medical practices and care centers. Revenue from software licensing to support e-prescription requirements.
3. Media Sales: Sale of pharmaceutical reference books, journals, and software media products to healthcare professionals and organizations.
4. Online Advertising: Advertising space sold on Gelbe Liste Online and Meine Gesundheit platforms through AdSpirit AdServer and Google Ads.
5. Data Services: Raw pharmaceutical data and web services sold to software houses and healthcare IT companies for integration into their own applications.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

Core offering

Vidal MMI Germany GmbH provides independently prepared, certified pharmaceutical drug databases and software solutions for the German healthcare market. Its core offerings include the MMI Pharmindex product family (Plus desktop software, Pro web service, Rohdaten raw data feeds), the MMI-AMTS-Service for medication therapy safety checks, the KBV-certified data4doc electronic prescription software, and the medic Cloud-Service for real-time drug data delivery. These are complemented by the Gelbe Liste Pharmindex cross-media platform and CME education portal, plus the Rehakliniken rehabilitation facility directory and Meine Gesundheit patient health portal.

Product overview

Vidal MMI Germany GmbH offers a comprehensive portfolio of pharmaceutical drug databases and software solutions. The core MMI Pharmindex product line includes three tiers: MMI Pharmindex Plus (certified desktop software for practices, clinics, and institutions), MMI Pharmindex Pro (web-service API for system integration), and MMI Pharmindex Rohdaten (raw data for custom integrations). Supporting the core databases are the MMI-AMTS-Service (medication safety module) and data4doc (KBV-certified e-prescribing software). The medic Cloud-Service enables real-time data feeds into third-party software and mobile apps. On the consumer-facing side, the Gelbe Liste Pharmindex sub-brand spans an online database, mobile app, and IDENTA identifier, supplemented by Gelbe Liste Campus (CME education). Additional verticals include Rehakliniken (rehabilitation facility directory) and Meine Gesundheit (patient health portal).

Differentiator

Problem solved

Functional benefit

Brands

• Gelbe Liste Pharmindex: Cross-media news and information platform for pharmaceuticals and active ingredients for medical professionals.
• MMI Pharmindex
• data4doc
• Meine Gesundheit
• Rehakliniken
• medic Cloud-Service

Products and services

• MMI Pharmindex Plus Certified pharmaceutical drug database software with extended functions and modules for medical practices, clinics, nursing homes, authorities, and companies. Provides comprehensive drug information, interactions, and clinical decision support for healthcare professionals.
• MMI Pharmindex Pro Standardized web service for pharmaceutical drug database integration into proprietary applications, practice management systems, and hospital information systems. Enables API-based access to certified drug data for software houses and IT integrators.
• MMI Pharmindex Rohdaten Structured raw pharmaceutical drug database for integration into proprietary applications, clinic, and practice management systems. Provides raw data feeds for custom development by software houses and healthcare IT companies.
• MMI-AMTS-Service Platform-independent medication therapy safety (AMTS) software for software vendors focused on physician software and hospital software. Detects drug interactions, contraindications, and patient-specific factors such as age or kidney function during prescribing.
• data4doc Verordnungssoftware KBV-certified software for electronic prescribing (E-Rezept) in medical practices and care centers. Supports dental practices with the mandatory electronic prescription requirements in Germany, enabling legally compliant digital prescribing.
• medic Cloud-Service Cloud-based solution delivering pharmaceutical drug data in real-time, easily integrable into software and mobile applications. Provides live data updates for software vendors and app developers needing current drug information.
• Gelbe Liste Pharmindex Cross-media pharmaceutical news and information platform covering drugs and active substances for healthcare professionals (Fachkreise). Positioned as the most comprehensive pharmaceutical database in the German-speaking internet, available as online portal, mobile app, and IDENTA identifier service.
• Gelbe Liste Campus Online CME continuing education platform for physicians, offering accredited medical knowledge courses. Targeted at forward-thinking physicians seeking ongoing medical education in a digital format.
• Rehakliniken Handbook and online database of rehabilitation and preventive care facilities in the German-speaking region. Available as both a printed reference work and an online searchable directory at rehakliniken.de.
• Meine Gesundheit Patient-facing health portal covering medicine, diseases and symptoms, nutrition, fitness, and wellness topics. Positioned as an advisor resource for patients, relatives, and health-conscious individuals.

Quantifiable outcome

• Electronic patient record (ePA) compliance and medication therapy safety integrated into prescription workflows
• +1 more outcomes

Named customers7 records

Segments6 records

Ideal customer profiles6 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Three partnerships are on record, tiered core and flagship.

• Anbieter von Praxisverwaltungssystemen (PVS)coreTechnology or IntegrationPartnerships with practice management system (PVS) providers for integration of MMI pharmaceutical databases and AMTS services into their software solutions. Michael Geisel as Sales & Partner Manager Daten Services is responsible for these partnerships.
• Gesetzliche KrankenkassencoreGTM or Marketing PartnerPartnerships with statutory health insurance funds (gesetzliche Krankenkassen) for healthcare data services and expansion of healthcare information access.
• VIDAL GroupflagshipOthersParent company and global leader in health informatics with headquarters in Paris. Vidal MMI Germany is part of the VIDAL Group, a leading global company in healthcare informatics and information systems.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• ifap Service-Institut für Ärzte und Apotheker GmbH: German drug information and clinical decision support provider offering pharmaceutical databases and interaction checks integrated into physician and pharmacy software. Directly comparable to Vidal MMI's Pharmindex and AMTS offerings in the German market.
• Rote Liste Service GmbH: Publisher of the Rote Liste, a long-standing German pharmaceutical reference used by physicians and pharmacists. Competes with MMI's Gelbe Liste Pharmindex as a printed and digital drug information reference in the German-speaking market.
• ABDA - Bundesvereinigung Deutscher Apothekerverbände (ABDA-Datenbank): Operates the ABDA-Datenbank, the central pharmaceutical database for German pharmacies. Overlaps with MMI in providing drug and interaction data, with a stronger pharmacy-side footprint versus MMI's physician/clinic orientation.
• ID Information und Dokumentation im Gesundheitswesen GmbH: German provider of pharmaceutical and medical product information, including the ID-Logistik drug database used by software houses and pharmacies. Directly comparable to MMI Pharmindex as a structured drug-data feed for German healthcare IT.

Broad incumbents

• CompuGroup Medical (CGM): One of the largest European healthcare-IT vendors, providing PVS (practice) and hospital information systems that embed drug databases and decision support. Comparable because it both consumes and competes with MMI's data layer across the German PVS ecosystem.
• Wolters Kluwer Health (Medi-Span / UpToDate Lexidrug): Global provider of drug information, clinical decision support and medication safety databases (Medi-Span, Lexicomp). Comparable to MMI at the international drug-data and AMTS level, though MMI is local-market-specialized.
• First Databank (FDB): US-headquartered supplier of drug and clinical decision support data integrated into EHRs and pharmacy systems. Comparable to MMI in providing foundational drug databases and interaction/AMTS checks, with a global footprint versus MMI's German focus.
• Elsevier (Clinical Solutions / Gold Standard Drug Database): Global publisher of clinical decision support and drug reference content. Comparable to MMI on the drug information and clinical reference dimension, with broader global distribution.
• Oracle Health (formerly Cerner): Major EHR vendor embedding medication safety and drug databases directly into its platforms. Comparable to MMI in bundling AMTS-style decision support, though at much larger scale and global scope.

Emerging players

• DocCheck Medical Services: German healthcare-professional platform offering drug information, CME and clinical content. Comparable to MMI on the clinician-facing content/CME and advertising side (e.g., Gelbe Liste Campus), though not a direct drug-database competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/medizinische-medien-informations-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medizinische Medien Informations GmbH